how deep to inject semaglutide An Advanced Guide Injection Sites & Rotation Strategy SEMAGLUTIDE INJECTION

Month 3 and Beyond: Long-Term Weight Loss Expectations Clinical trial data shows that patients using GLP-1 medications maintain an average weight loss of 15 to 22% of their starting body weight after 6 months of consistent use

So the side effects that I have experienced is constipation and nausea

Inositol supplementation and insulin sensitivity

However, these weight loss medications are not recommended for use during pregnancy, and ideally should be stopped at least 2 months before any planned pregnancy

PMID: 117 RogerB.PapinJ.VacherP.RaouxM.MulotA.DuboisM.et al

[DOI] [PMC free article] [PubMed] [Google Scholar] 51.Gast K.B., Tjeerdema N., Stijnen T., Smit J.W.A., Dekkers O.M